| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5ad8562c578b061df7a2c3aee9d0e24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87b8b0fc9402429603f11cca4b9a107f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-66 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-66 |
| filingDate |
2020-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_291e538388d2d0bb94437de2295e8253
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b28fd0dfe6073698bf0946a3610ef7f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_914355a7ec2bc7dc9634a4a58828ca3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93a12948f51034fa1e87dd5df8faf22f |
| publicationDate |
2021-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210157148-A |
| titleOfInvention |
Pharmaceutical composition for preventing or treating dry eye syndrome or degenerative brain disease comprising extracts of Papaver rhoeas or fractions thereof as an active ingredient |
| abstract |
The present invention relates to a pharmaceutical composition for preventing or treating dry eye syndrome or degenerative brain disease containing a poppy leaf extract or a fraction thereof as an active ingredient, and the poppy poppy ( Papaver rhoeas ) extract or fraction thereof of the present invention is effective for oxidative stress. By increasing the degree of conjunctival cell protective activity against and alleviating the condition of degenerative brain disease, the poppy extract or its fraction can be usefully used as a pharmaceutical composition or health functional food composition for the prevention or treatment of dry eye syndrome or degenerative brain disease. It can contribute to reducing social costs and improving quality of life in an aging society through the development of materials for improving cognitive abilities. |
| priorityDate |
2020-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |